ClinConnect ClinConnect Logo
Search / Trial NCT05922566

Research on the Influence of Mukbang on Brain Activation in Children With Cancer Based on fMRI

Launched by WEI XIA, PHD · Jun 19, 2023

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Childhood Cancer Mukbang Functional Magnetic Resonance Imaging Appetite

ClinConnect Summary

This clinical trial is exploring how "Mukbang," which is a popular trend of watching people eat large amounts of food, can help improve appetite in children with cancer who are undergoing treatments like chemotherapy and radiotherapy. The study will use a special type of brain scan called fMRI to see how watching Mukbang might affect the brain and encourage these children to eat better during their treatment.

To participate in this trial, children aged 10 to 18 who have been diagnosed with any type of cancer (except brain tumors) and are currently receiving treatment can apply. They should also have a noticeable decrease in appetite. However, children with serious other health issues, certain mental or physical disabilities, or conditions that prevent them from comfortably watching videos will not be eligible. If they join the study, participants will watch Mukbang videos while their brain activity is monitored, helping researchers understand how these videos might support better eating habits during tough treatment times.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • children with cancer aged between 10 to 18 years old;
  • diagnosed with any tumor or cancer other than brain tumor before the age of 18;
  • having received or are receiving inpatient treatment;
  • both the patient and the guardian can communicate in Chinese;
  • children with moderate or higher symptoms of decreased appetite were screened for the Therapy-Related Symptom Checklist for Children.
  • Exclusion Criteria:
  • a diagnosis of a serious disease other than a tumor, especially a brain disease such as epilepsy and organic psychosis, was identified from the case;
  • unable to complete communication due to serious mental or physical illness, such as cognitive impairment or unclear consciousness;
  • children with eye or ear dysfunction that prevents them from watching and listening to videos;
  • with braces, cardiac pacemakers and other items with iron magnetism that cannot be removed from the body;
  • people who suffer from claustrophobia, ADHD, and other problems of staying quiet in confined spaces for long periods of time.

About Wei Xia, Phd

Wei Xia, PhD, is a distinguished clinical trial sponsor with extensive expertise in clinical research and development. With a strong background in biomedical sciences, Dr. Xia has a proven track record of leading innovative studies aimed at advancing therapeutic interventions. His commitment to rigorous scientific methodologies and ethical standards ensures the integrity and reliability of clinical trials. Dr. Xia's collaborative approach fosters partnerships with academic institutions and industry stakeholders, driving forward the translation of research findings into impactful healthcare solutions.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Trial Officials

Wei Xia

Principal Investigator

Sun Yat-sen University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported